MRI contrast developer Epix Pharmaceuticals' common stock will resume trading under its previous ticker symbol, EPIX, effective immediately.
Nasdaq officials had changed the designation to EPIXD following the closing of the Cambridge, MA, company's merger with Predix Pharmaceuticals of Lexington, MA, on August 16.
By AuntMinnie.com staff writers
September 15, 2006
Related Reading
FDA rejects Epix appeal, August 28, 2006
Epix, Predix complete merger, August 17, 2006
Epix, Predix shareholders approve merger, August 15, 2006
Epix nears Australia approval for Vasovist, August 14, 2006
Epix grows revenues in Q2, August 7, 2006
Copyright © 2006 AuntMinnie.com
